Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,693,000 | 3,192,000 | 2,962,000 | 2,790,000 | 2,746,000 |
| Marketable Securities | 21,000 | 20,000 | 21,000 | 1,305,000 | 2,246,000 |
| Inventories | 5,669,000 | 5,918,000 | 5,859,000 | 5,702,000 | 5,498,000 |
| Other current assets | 7,224,000 | 8,168,000 | 7,922,000 | 7,408,000 | 7,799,000 |
| TOTAL | $16,997,000 | $17,298,000 | $16,764,000 | $17,205,000 | $18,644,000 |
| Non-Current Assets | |||||
| PPE Net | 10,073,000 | 9,725,000 | 9,823,000 | 9,867,000 | 9,957,000 |
| Intangibles | 22,497,000 | 21,690,000 | 22,433,000 | 22,645,000 | 21,579,000 |
| Other Non-Current Assets | 9,896,000 | 9,336,000 | 9,046,000 | 8,794,000 | 8,825,000 |
| TOTAL | $42,466,000 | $40,751,000 | $41,302,000 | $41,306,000 | $40,361,000 |
| Total Assets | $59,463,000 | $58,049,000 | $58,066,000 | $58,511,000 | $59,005,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,181,000 | N/A | N/A | N/A | 2,657,000 |
| Accounts payable and accrued liabilities | 3,462,000 | 14,375,000 | 14,245,000 | 14,621,000 | 3,717,000 |
| Other current liabilities | 1,172,000 | 1,105,000 | 1,095,000 | 1,094,000 | 1,053,000 |
| TOTAL | $21,697,000 | $21,459,000 | $20,345,000 | $19,846,000 | $21,068,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,703,000 | N/A | N/A | N/A | 14,154,000 |
| Other Non-Current Liabilities | 10,081,000 | 23,398,000 | 24,263,000 | 25,759,000 | 9,924,000 |
| TOTAL | $24,680,000 | $23,137,000 | $23,951,000 | $25,436,000 | $25,142,000 |
| Total Liabilities | $46,377,000 | $44,596,000 | $44,296,000 | $45,282,000 | $46,210,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,348,000 | 1,348,000 | 1,348,000 | 1,348,000 | 1,348,000 |
| Retained earnings | 7,796,000 | 8,187,000 | 8,583,000 | 7,935,000 | 7,239,000 |
| Other shareholders' equity | 1,054,000 | 1,000,000 | 969,000 | 1,086,000 | 1,309,000 |
| TOTAL | $13,671,000 | $14,008,000 | $14,372,000 | $13,840,000 | $13,347,000 |
| Total Liabilities And Equity | $60,048,000 | $58,604,000 | $58,668,000 | $59,122,000 | $59,557,000 |